People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type ...

The drugmaker Lilly announced topline results of a clinical trial of a new pill in the same drug class as injectables like ...

A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and ...

Injectable drugs require refrigeration when they are stored or transported, and the pill potentially opens up the market ...

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

A once-daily oral GLP-1 conferred greater reductions in HbA1c and body weight than placebo among adults with type 2 diabetes, ...

Explore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...

Diabetes mellitus is most commonly known as diabetes, which is a disease that affects how the body uses glucose or blood ...